The firm already markets recently-approved Entresto (sacubitril+valsartan) to treat heart failure, and diabetes drug Galvus (vildagliptin) through its cardio-metabolic division, and is looking to ...

MSN Pharma was given FDA approval for its Entresto (sacubitril and valsartan) generic on 24th ... Entresto that would infringe a patent on the drug (No. 11,096,918) that confers protection until ...

Since 2022, it has been the cause of major epidemics spreading outside endemic ... Drug May Counteract Muscle Loss and Osteoporosis After Rapid Weight Loss Feb. 10, 2025 — Rapid weight loss ...

Histamine receptor, a typical G-protein-coupled receptor (GPCR), is important mediator of signalling and is responsible for regulation of human autoimmunity. Here, the authors report an artificial ...